LRP1: a novel receptor for the transmission of pathological α-Synuclein

Mol Neurodegener. 2022 Nov 26;17(1):79. doi: 10.1186/s13024-022-00582-4.

Authors

Crystal Pan¹, Chao Peng²

Affiliations

¹ Department of Neurology, David Geffen School of Medicine, University of California - Los Angeles, 90095, Los Angeles, CA, USA.
² Department of Neurology, David Geffen School of Medicine, University of California - Los Angeles, 90095, Los Angeles, CA, USA. cpeng@mednet.ucla.edu.

No abstract available

Keywords: LRP1; Parkinson’s disease; Receptor mediated endocytosis; α-Synuclein.

Publication types

Research Support, Non-U.S. Gov't
Research Support, N.I.H., Extramural

MeSH terms

Neurons*
alpha-Synuclein*

Substances

alpha-Synuclein

Grants and funding

R01 NS128964/NS/NINDS NIH HHS/United States